Close Menu

US Patent No. 9,464,327

Recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma
Oct 12, 2016

The Chinese University of Hong Kong has been awarded US Patent No. 9,464,327, "Recurrent transforming UBR5-ZNF423 fusion gene in EBV-associated nasopharyngeal carcinoma."

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.

Mar
27
Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost. 

Apr
24
Sponsored by
Biocrates

This webinar will provide a wide-ranging overview of the promise for metabolomics in studying human health and disease, as well as its potential for integration with other -omics disciplines.